Effects of Leadership in the Management Strategies of Merck and Company‚ Inc. Rana Satnani MGT-330 Management: Theory‚ Practice‚ and Application. July 2‚ 2010 Carolyn Harrison There lies a division in the business world between managers who “do things right” and leaders who “do the right things” (Bennis‚ 2007‚ p. 13). The primary difference between good managers and fantastic leaders is the ability to take risks and make independent decisions. Ethical leadership is more important today than
Premium Leadership Management Business ethics
The Case Against Merck and Co.‚ Inc. Chris Brefeld August 2‚ 2010 The Case of Merck and Co.‚ Inc. Merck and Co.‚ Inc. is one of the largest pharmaceutical companies in the world with a market capitalization of over $110 billion dollars. The company describes itself as a global research-driven pharmaceutical company that discovers‚ develops‚ manufactures‚ and markets vaccines and medicines to address unmet medical needs. The company also makes an effort to increase access to its medicine
Premium Atherosclerosis Pharmaceutical industry Clinical trial
Merck is a pharmaceutical company that we often see on television for their prescription drug ads. They were known for their ability to produce 13 new drugs from 1995 to 2001‚ of which included the painkiller Vioxx. The drug was supposed to beat out Pfizer’s‚ Celebrex‚ and Bextra because it was gentler on the stomach. (www.cbsnews.com) But was that the only thing different Vioxx could do? Vioxx was introduced in 1999. Almost immediately reports started pouring in about patients having complications
Premium Pharmacology Pharmaceutical drug Drug
River Blindness MERCK AND RIVER BLINDNESS Does Dr. Roy Vagelos or Merck and Co. have a responsibility to pursue R&D for a human version of Ivermectin‚ the drug for river blindness? Lets take this question to a positive evaluation. Developing a drug to combat river blindness has potential costs and benefits. Merck discovered an opportunity to treat millions of infected people around the world but knew that the drug would probably never see commercial use. Investing millions
Premium Pharmacology Medicine Pharmaceutical drug
Merck and Co.‚ River Blindness Ethical Case Analysis Lennard de Jong Excelsior College Author Note This paper was prepared for Business Ethics‚ Ethical Case Analysis‚ taught by Dr. Moser. Introduction and Situational Analysis The ethical dilemma in Merck and River Blindness is whether to pursue research that may or may result in profit‚ or to choose the safe option and go for profit rather than researching the drug. The drug could possibly lead to curing the deadly and detrimental disease
Premium Ethics Morality
Merck & Co.‚ Inc. Case If one hold a key to resolve a very serious problem‚ one has a responsibility to put an effort to make it happen‚ at least try one’s best. In this case‚ river blindness disease was a very serious problem‚ and Dr. Vagelos was the one who could make a decision as to whether the research and development of a human version of ivermectin should be carried on‚ then it was his responsibility to pursue it. Caused by a parasitic worm carried by a tiny black fly‚ the disease
Premium Blindness Human Onchocerciasis
MAN 4720 Nov. 15‚ 2011 Merck‚ the FDA‚ and the Vioxx Recall In 1999 the Food and Drug Administration (FDA) had approved Vioxx‚ what would become Merck’s “blockbuster” drug. Although the FDA had approved the drug there was uncertainty of the safety of drug. Vioxx was approved to treat a variety of conditions‚ such as osteoarthritis and acute pain‚ but there was also a chance that it would increase cardiovascular problems. What I found most interesting about this case was the changes in how drugs
Premium Pharmacology Advertising Clinical trial
Innovative Integrated Management System (IIMS) for Sustainable Food Industry Assoc. Prof. Dr. Prasert Suttiprasit Director of The Centre for Standards and Quality Development of Production and Services Sukhothai Thammathirat Open University Nonthaburi 11120‚ Thailand Tel. +668-1346-9000 Email. prasert_sp@yahoo.com ABSTRACT It is evident that the long-term survival and growth of global food industry depend on the availability and efficient use of raw materials‚ energy and water and other
Premium Process management Food Food safety
Domestic drug manufacturers have cast their eyes overseas for growth and four of them have received the certificate of pharmaceutical product (CPP)‚ one of the pre-requisites for obtaining an export licence from the Department of Drug Administration (DDA). According to the DDA‚ Lomus Pharmaceuticals‚ Deurali-Janata Pharmaceuticals‚ Elder Pharmaceuticals and National Health Care Nepal have received the CPP. The CPP is a must for drug manufacturers wanting to export their products. Once the CPP has
Premium Pharmacology Pharmaceutical drug Drug
1. Concepcion-Carrier Air Conditioning Company Formed in January 1998‚ Concepcion-Carrier Air Conditioning Company (CCAC) brings together two leaders in the air conditioning industry: Carrier Corporation of the United States and Concepcion Industries‚ Inc. of the Philippines. In just a few years‚ CCAC expanded from manufacturing window room air conditioners to becoming the market leader in virtually all categories of Heating‚ Ventilating and Air Conditioning (HVAC) equipment and services in
Premium HVAC Air conditioning